Philip Bergman | Director Of Clinical Studies
V.C.A. Antech Inc
Dr. Bergman is the Director of Clinical Studies for VCA. He is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center and the principal veterinary investigator for the canine melanoma vaccine (Oncept®), which was fully licensed in 2009. Prior to Dr. Bergman joining VCA, he served as the Chief Medical Officer for BrightHeart Veterinary Centers from 2007 to 2011; from 1999 – 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC. After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (‘90-‘91) and returned to CSU for his medical oncology residency (‘91-‘94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (‘94-‘99). He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.
Appearances:
Pre-congress Workshops, April 6 @ 10:00
WORKSHOP B (FULL DAY): ANIMAL HEALTH
AM: SCIENTIFIC ADVANCEMENTS IN THE COMPANION ANIMAL CANCER VACCINE SPACEWorkshop Leader: Philip J. Bergman- Overcoming current limitations in selecting immunogenic neoantigens
- Bridging the gap between human and animal cancer: translational studies of a polyvalent cancer preventative vaccine
- Personalized autologous cancer vaccine for cats & dogs
- Development of an animal health vaccine using gene-based checkpoint inhibitors
- The safety of an adjuvanted autologous cancer vaccine platform in canine cancer patients
- From treating veterinary cancers to launching a first-in-human clinical trial
Sign Up for Event Updates
Organiser
